marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-05-2024
USANA Health Sciences Balance Sheet 2011-2024 | USNA
Annual Balance Sheet USANA Health Sciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-318 M | -274 M | - | - | -235 M | -214 M | -247 M | -143 M | -111 M | - | -137 M | -70.8 M | -24.2 M |
Long Term Debt |
5.14 M | 7.68 M | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
7.28 M | 6.89 M | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 29.1 M | 14.6 M | 14.9 M | 11 M | 11.7 M | - | 12 M | 11 M | 10.8 M |
Total Current Liabilities |
119 M | 144 M | 168 M | - | 136 M | 149 M | 141 M | 138 M | 109 M | - | 95.9 M | 70.8 M | 59.7 M |
Total Liabilities |
- | - | - | - | 165 M | 163 M | 156 M | 142 M | 120 M | - | 108 M | 81.8 M | 69.8 M |
Deferred Revenue |
13.9 M | 20.9 M | 16 M | - | 2.73 M | 2.65 M | 17 M | 17.6 M | 15.7 M | - | 16.1 M | 15.6 M | 1.71 M |
Retained Earnings |
445 M | 392 M | 383 M | - | 306 M | 330 M | 288 M | 215 M | 166 M | - | 200 M | 135 M | 90.2 M |
Total Assets |
633 M | 597 M | 641 M | - | 517 M | 554 M | 519 M | 423 M | 351 M | - | 368 M | 267 M | 217 M |
Cash and Cash Equivalents |
330 M | 288 M | 312 M | - | 235 M | 214 M | 247 M | 176 M | 111 M | - | 137 M | 70.8 M | 50.4 M |
Book Value |
633 M | 597 M | 641 M | - | 352 M | 391 M | 363 M | 281 M | 230 M | - | 261 M | 186 M | 147 M |
Total Shareholders Equity |
497 M | 434 M | 442 M | - | 352 M | 391 M | 363 M | 325 M | 230 M | - | 261 M | 186 M | 174 M |
All numbers in USD currency
Quarterly Balance Sheet USANA Health Sciences
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 17.3 M | 12.6 M | 12.6 M | 11.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | 19.6 M | - | - | - | 16 M | - | - | - | - | - | - | - | 13.9 M | - | - | - | 2.65 M | - | - | - | 3.06 M | - | - | - | 21.5 M | - | - | - | 15.7 M | - | - | - | - | - | - | - | 16.1 M | - | - | - | 15.6 M | - | - | - | 10.1 M | - | - | - |
Retained Earnings |
474 M | 464 M | 453 M | 445 M | 428 M | 427 M | 410 M | 392 M | 379 M | 364 M | 345 M | 383 M | 350 M | 366 M | 353 M | - | 343 M | 313 M | 285 M | 306 M | 306 M | 306 M | 306 M | 330 M | 330 M | 330 M | 330 M | 288 M | 288 M | 288 M | 288 M | 265 M | 265 M | 265 M | 265 M | 166 M | 237 M | 212 M | 186 M | - | 156 M | 197 M | 217 M | 200 M | 200 M | 200 M | 200 M | 135 M | 135 M | 135 M | 135 M | 119 M | 119 M | 119 M | 119 M |
Total Assets |
671 M | 631 M | 629 M | 633 M | 601 M | 603 M | 606 M | 597 M | 556 M | 558 M | 573 M | 641 M | 579 M | 591 M | 585 M | - | 578 M | 512 M | 474 M | 517 M | 517 M | 517 M | 517 M | 554 M | 554 M | 554 M | 554 M | 519 M | 519 M | 519 M | 519 M | 471 M | 471 M | 471 M | 471 M | 351 M | 439 M | 409 M | 375 M | - | 317 M | 355 M | 371 M | 368 M | 368 M | 368 M | 368 M | 267 M | 267 M | 267 M | 267 M | 244 M | 244 M | 244 M | 244 M |
Cash and Cash Equivalents |
365 M | 332 M | 328 M | 330 M | 307 M | 300 M | 295 M | 288 M | 247 M | 230 M | 238 M | 312 M | 249 M | 265 M | 257 M | - | 278 M | 227 M | 194 M | 235 M | 235 M | 235 M | 235 M | 214 M | 214 M | 214 M | 214 M | 247 M | 247 M | 247 M | 247 M | 176 M | 176 M | 176 M | 176 M | 111 M | 174 M | 151 M | 129 M | - | 87.7 M | 118 M | 143 M | 137 M | 137 M | 137 M | 137 M | 70.8 M | 70.8 M | 70.8 M | 70.8 M | 50.4 M | 50.4 M | 50.4 M | 50.4 M |
Book Value |
671 M | 631 M | 629 M | 633 M | 601 M | 603 M | 606 M | 597 M | 556 M | 558 M | 573 M | 641 M | 579 M | 591 M | 585 M | - | 578 M | 512 M | 474 M | 517 M | 517 M | 517 M | 517 M | 554 M | 554 M | 554 M | 554 M | 519 M | 519 M | 519 M | 519 M | 471 M | 471 M | 471 M | 471 M | 351 M | 439 M | 409 M | 375 M | - | 317 M | 355 M | 371 M | 368 M | 368 M | 368 M | 368 M | 267 M | 267 M | 267 M | 267 M | 244 M | 244 M | 244 M | 244 M |
Total Shareholders Equity |
533 M | 512 M | 500 M | 497 M | 470 M | 469 M | 455 M | 434 M | 411 M | 404 M | 390 M | 442 M | 399 M | 419 M | 403 M | - | 389 M | 349 M | 318 M | 352 M | 352 M | 352 M | 352 M | 391 M | 391 M | 391 M | 391 M | 363 M | 363 M | 363 M | 363 M | 325 M | 325 M | 325 M | 325 M | 230 M | 313 M | 285 M | 253 M | - | 199 M | 254 M | 280 M | 261 M | 261 M | 261 M | 261 M | 186 M | 186 M | 186 M | 186 M | 174 M | 174 M | 174 M | 174 M |
All numbers in USD currency